表紙:在宅輸液療法の世界市場の規模:製品別、用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)
市場調査レポート
商品コード
1149669

在宅輸液療法の世界市場の規模:製品別、用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)

Home Infusion Therapy Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 144 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
在宅輸液療法の世界市場の規模:製品別、用途別、業界分析、地域の見通し、成長可能性、価格動向、競合の市場シェア、予測(2023年~2032年)
出版日: 2022年11月03日
発行: Global Market Insights Inc.
ページ情報: 英文 144 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の在宅輸液療法市場は、外来患者数の増加により2032年にかけて大幅に成長すると予測されています。

加えて、在宅での治療や手術後の治療に対する選好の高まりも、在宅輸液療法機器の使用を加速させています。

当レポートでは、世界の在宅輸液療法市場について調査分析し、業界の考察、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 在宅輸液療法業界の考察

  • 業界セグメンテーション
  • 業界情勢(2018年~2032年)
  • 業界の影響要因
    • 成長促進要因
    • 業界の潜在的リスク・課題
  • 成長可能性分析
    • 製品別
    • 用途別
  • COVID-19の影響の分析
  • 在宅輸液療法業界の動向
  • 在宅輸液療法業界の将来の見通し
  • 規制情勢
    • 米国
    • 欧州
  • ポーターのファイブフォース分析
  • PESTLE分析

第4章 競合情勢(2021年)

  • イントロダクション
  • 企業マトリックス分析(2021年)
  • 戦略ダッシュボード(2021年)

第5章 在宅輸液療法市場:製品別

  • 主なセグメントの動向
  • 輸液ポンプ
  • 点滴セット
  • IVカニューレ
  • 無針コネクタ

第6章 在宅輸液療法市場:用途別

  • 主なセグメントの動向
  • 抗感染症
  • 水分補給療法
  • 化学療法
  • 経腸栄養
  • 静脈栄養
  • 特殊医薬品
  • その他

第7章 在宅輸液療法市場:地域別

  • 主な地域の動向
  • 北米
    • 市場規模:国別(2018年~2032年)
    • 市場規模:製品別(2018年~2032年)
    • 市場規模:用途別(2018年~2032年)
    • 米国
    • カナダ
  • 欧州
    • 市場規模:国別(2018年~2032年)
    • 市場規模:製品別(2018年~2032年)
    • 市場規模:用途別(2018年~2032年)
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
  • アジア太平洋
    • 市場規模:国別(2018年~2032年)
    • 市場規模:製品別(2018年~2032年)
    • 市場規模:用途別(2018年~2032年)
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • 市場規模:国別(2018年~2032年)
    • 市場規模:製品別(2018年~2032年)
    • 市場規模:用途別(2018年~2032年)
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 市場規模:国別(2018年~2032年)
    • 市場規模:製品別(2018年~2032年)
    • 市場規模:用途別(2018年~2032年)
    • 南アフリカ

第8章 企業プロファイル

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Fresenius Kabi
  • ICU Medical Inc.
  • Terumo Corporation
  • Moog Inc.
  • Halyard Health, Inc. (Avanos Medical)
  • Amsino International, Inc.
  • Lepu Medical Technology
  • Erenler Medikal
  • Contec Medical Systems Co. Ltd
  • JMS Co. Ltd.
図表

Data Tables

  • TABLE 1 Global home infusion therapy market, 2018 - 2022 (USD Million)
  • TABLE 2 Global home infusion therapy market, 2023 - 2032 (USD Million)
  • TABLE 3 Global home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 4 Global home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 5 Global home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 6 Global home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 7 Global home infusion therapy market, by region, 2018 - 2022 (USD Million)
  • TABLE 8 Global home infusion therapy market, by region, 2023 - 2032 (USD Million)
  • TABLE 9 Industry impact forces
  • TABLE 10 Infusion pumps market, by region, 2018 - 2022 (USD Million)
  • TABLE 11 Infusion pumps market, by region, 2023 - 2032 (USD Million)
  • TABLE 12 Intravenous sets market, by region, 2018 - 2022 (USD Million)
  • TABLE 13 Intravenous sets market, by region, 2023 - 2032 (USD Million)
  • TABLE 14 IV cannulas market, by region, 2018 - 2022 (USD Million)
  • TABLE 15 IV cannulas market, by region, 2023 - 2032 (USD Million)
  • TABLE 16 Needleless connectors market, by region, 2018 - 2022 (USD Million)
  • TABLE 17 Needleless connectors market, by region, 2023 - 2032 (USD Million)
  • TABLE 18 Anti-infective market, by region, 2018 - 2022 (USD Million)
  • TABLE 19 Anti-infective market, by region, 2023 - 2032 (USD Million)
  • TABLE 20 Hydration therapy market, by region, 2018 - 2022 (USD Million)
  • TABLE 21 Hydration therapy market, by region, 2023 - 2032 (USD Million)
  • TABLE 22 Chemotherapy market, by region, 2018 - 2022 (USD Million)
  • TABLE 23 Chemotherapy market, by region, 2023 - 2032 (USD Million)
  • TABLE 24 Enteral nutrition market, by region, 2018 - 2022 (USD Million)
  • TABLE 25 Enteral nutrition market, by region, 2023 - 2032 (USD Million)
  • TABLE 26 Parenteral nutrition market, by region, 2018 - 2022 (USD Million)
  • TABLE 27 Parenteral nutrition market, by region, 2023 - 2032 (USD Million)
  • TABLE 28 Speciality pharmaceuticals market, by region, 2018 - 2022 (USD Million)
  • TABLE 29 Speciality pharmaceuticals market, by region, 2023 - 2032 (USD Million)
  • TABLE 30 Others market, by region, 2018 - 2022 (USD Million)
  • TABLE 31 Others market, by region, 2023 - 2032 (USD Million)
  • TABLE 32 North America home infusion therapy market, by country, 2018 - 2022 (USD Million)
  • TABLE 33 North America home infusion therapy market, by country, 2023 - 2032 (USD Million)
  • TABLE 34 North America home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 35 North America home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 36 North America home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 37 North America home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 38 U.S. home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 39 U.S. home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 40 U.S. home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 41 U.S. home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 42 Canada home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 43 Canada home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 44 Canada home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 45 Canada home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 46 Europe home infusion therapy market, by country, 2018 - 2022 (USD Million)
  • TABLE 47 Europe home infusion therapy market, by country, 2023 - 2032 (USD Million)
  • TABLE 48 Europe home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 49 Europe home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 50 Europe home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 51 Europe home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 52 Germany home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 53 Germany home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 54 Germany home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 55 Germany home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 56 UK home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 57 UK home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 58 UK home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 59 UK home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 60 France home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 61 France home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 62 France home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 63 France home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 64 Spain home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 65 Spain home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 66 Spain home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 67 Spain home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 68 Italy home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 69 Italy home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 70 Italy home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 71 Italy home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 72 Asia Pacific home infusion therapy market, by country, 2018 - 2022 (USD Million)
  • TABLE 73 Asia Pacific home infusion therapy market, by country, 2023 - 2032 (USD Million)
  • TABLE 74 Asia Pacific home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 75 Asia Pacific home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 76 Asia Pacific home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 77 Asia Pacific home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 78 China home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 79 China home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 80 China home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 81 China home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 82 Japan home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 83 Japan home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 84 Japan home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 85 Japan home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 86 India home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 87 India home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 88 India home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 89 India home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 90 Australia home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 91 Australia home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 92 Australia home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 93 Australia home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 94 South Korea home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 95 South Korea home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 96 South Korea home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 97 South Korea home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 98 Latin America home infusion therapy market, by country, 2018 - 2022 (USD Million)
  • TABLE 99 Latin America home infusion therapy market, by country, 2023 - 2032 (USD Million)
  • TABLE 100 Latin America home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 101 Latin America home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 102 Latin America home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 103 Latin America home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 104 Brazil home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 105 Brazil home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 106 Brazil home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 107 Brazil home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 108 Mexico home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 109 Mexico home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 110 Mexico home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 111 Mexico home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 112 MEA home infusion therapy market, by country, 2018 - 2022 (USD Million)
  • TABLE 113 MEA home infusion therapy market, by country, 2023 - 2032 (USD Million)
  • TABLE 114 MEA home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 115 MEA home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 116 MEA home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 117 MEA home infusion therapy market, by application, 2023 - 2032 (USD Million)
  • TABLE 118 South Africa home infusion therapy market, by product, 2018 - 2022 (USD Million)
  • TABLE 119 South Africa home infusion therapy market, by product, 2023 - 2032 (USD Million)
  • TABLE 120 South Africa home infusion therapy market, by application, 2018 - 2022 (USD Million)
  • TABLE 121 South Africa home infusion therapy market, by application, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Home infusion therapy industry 360o synopsis, 2018 - 2032
  • FIG. 4 Industry segmentation
  • FIG. 5 Global home infusion therapy market, 2018 - 2032 (USD Million)
  • FIG. 6 Growth potential analysis, by product
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Porter's Analysis
  • FIG. 9 Company matrix analysis, 2021
  • FIG. 10 PESTEL Analysis
  • FIG. 11 Strategy dashboard, 2021
  • FIG. 12 Key segment trends, by product
  • FIG. 13 Key segment trends, by application
  • FIG. 14 Key regional trends
目次
Product Code: 435

The home infusion therapy market is slated to grow at a substantial rate over 2032, owing to the rising number of outpatient visits. In addition, increasing preference for at-home treatment or post-surgery treatment are also accelerating the use of home infusion therapy devices. Patients that require long-term treatment mostly choose at-home therapy options.

A wide variety of home infusion therapies are available to treat different chronic illnesses. Specialty infusions are administered to patients with hemophilia, arthritis, congestive heart failure, Crohn's disease, multiple sclerosis (MS), high-risk pregnancy, and several immune deficiencies.

Rising prevalence of hormone disorders and rare diseases has fueled the need for drug therapies involving the administration of antibiotics, total parenteral nutrition (TPN), intravenous immunoglobulin (IVIG), and antivirals. To cope with side effects such as dehydration or soreness associated with intense treatments, physicians recommend home infusion therapy for pain management.

Technological advancements have enabled the development of next-generation smart infusion pumps as a part of clinical decision-support tools to ensure an accurate medication administration process. The advent of smart infusion pumps has enhanced accuracy and KVO with alarms, pressure control systems, and other smart features.

Leveraging recent healthcare trends such as smart diagnosis and treatment, telemedicine, and telehealth, various industry players are introducing novel home infusion devices. For instance, in August 2022, Baxter International Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new syringe infusion pump (SYR) called Novum IQ. With the Dose IQ Software and IQ Enterprise connectivity suite, SYR can effectively integrate with electronic medical records.

The home infusion therapy market is segregated into product, application, and region.

Based on product, the industry is classified into infusion pumps, needless connectors, intravenous sets, and IV cannulas. Home infusion therapy market share from the needless connectors segment is expected to go beyond USD 25 billion by 2032. Needleless connectors are widely used for central, arterial, and peripheral catheters.

Increasing use of needle-free connectors can be attributed to the advantages such as faster and safer access to the infusion line and reduced risk of accidental puncture and infection. These devices also help prevent contamination of patients' catheters and reduce the risk of device occlusion.

With respect to application, the home infusion therapy market is fragmented into chemotherapy, hydration therapy, specialty pharmaceuticals, anti-infective, hydration therapy, enteral nutrition, parenteral nutrition, and others. The industry share from the specialty pharmaceuticals segment is poised to reach over USD 10.5 billion by 2032.

Specialty drugs are administered via home infusion systems to treat complex and rare diseases through monitored dosage. The rising prevalence of chronic diseases is expected to propel the demand for home infusion devices for the administration of specialty drugs.

From a regional perspective, the Asia Pacific home infusion therapy market is anticipated to exhibit over 12% CAGR by 2032. The presence of a robust geriatric population, increasing cases of cancer, and a growing burden on healthcare will complement regional industry growth. APAC countries such as India and China are ramping up efforts to incorporate skilled healthcare experts by providing training and incentivizing younger doctors.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Home infusion therapy industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Application trends
    • 2.1.4 Regional trends

Chapter 3 Home Infusion Therapy Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing hospital acquired infections
      • 3.3.1.2 Rising prevalence of chronic diseases
      • 3.3.1.3 Advancements in technology
      • 3.3.1.4 Growing geriatric population
      • 3.3.1.5 Increasing preference towards at-home healthcare solutions
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Dearth of reimbursement
      • 3.3.2.2 Safety concerns and risk of failure associated with home infusion devices
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By application
  • 3.5 COVID- 19 impact analysis
  • 3.6 Trends in home infusion therapy industry
  • 3.7 Future prospects for home infusion therapy industry
  • 3.8 Regulatory landscape
    • 3.8.1 U.S.
    • 3.8.2 Europe
  • 3.9 Porter's analysis
    • 3.9.1 Industry rivalry
    • 3.9.2 Suppliers power
    • 3.9.3 Buyer power
    • 3.9.4 Threat of substitute
    • 3.9.5 Threat of new entrants
  • 3.10 PESTLE Analysis
    • 3.10.1 Political
    • 3.10.2 Economical
    • 3.10.3 Social
    • 3.10.4 Technological
    • 3.10.5 Legal
    • 3.10.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Home Infusion Therapy Market, By Product

  • 5.1 Key segment trends
  • 5.2 Infusion pumps
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.3 Intravenous sets
    • 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.4 IV Cannulas
    • 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.5 Needleless connectors
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Home Infusion Therapy Market, By Application

  • 6.1 Key segment trends
  • 6.2 Anti-infective
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Hydration therapy
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.4 Chemotherapy
    • 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.5 Enteral nutrition
    • 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.6 Parenteral nutrition
    • 6.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.7 Specialty pharmaceuticals
    • 6.7.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Home Infusion Therapy Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.2.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.2.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.4 U.S.
      • 7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.2.5 Canada
      • 7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.3.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.3.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.4 Germany
      • 7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.5 UK
      • 7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.6 France
      • 7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.7 Spain
      • 7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.3.8 Italy
      • 7.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.3.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.4.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.4.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.4 China
      • 7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.5 Japan
      • 7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.6 India
      • 7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.7 Australia
      • 7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.4.8 South Korea
      • 7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.5.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.5.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.4 Brazil
      • 7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.4.2 Market size, by application, 2018 - 2032 (USD Million)
    • 7.5.5 Mexico
      • 7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
  • 7.6 MEA
    • 7.6.1 Market size, by country, 2018 - 2032 (USD Million)
    • 7.6.2 Market size, by product, 2018 - 2032 (USD Million)
    • 7.6.3 Market size, by application, 2018 - 2032 (USD Million)
    • 7.6.4 South Africa
      • 7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
      • 7.6.4.2 Market size, by application, 2018 - 2032 (USD Million)

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
    • 8.1.1 Business Overview
    • 8.1.2 Financial Data
    • 8.1.3 Product Landscape
    • 8.1.4 Strategic Outlook
    • 8.1.5 SWOT Analysis
  • 8.2 Baxter International Inc.
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 Strategic Outlook
    • 8.2.5 SWOT Analysis
  • 8.3 Becton Dickinson and Company
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 Fresenius Kabi
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 ICU Medical Inc.
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Terumo Corporation
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Moog Inc.
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 Halyard Health, Inc. (Avanos Medical)
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 Amsino International, Inc.
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 Lepu Medical Technology
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Erenler Medikal
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Contec Medical Systems Co. Ltd
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 JMS Co. Ltd.
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis